Physician profile
Yan Li
NPI 1619932076
$18,126.30
in general payments reported to CMS, 2019-2025
59 companies · $3,135 in 2025
The $3,135 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,754 · 2020: $1,124 · 2021: $2,272 · 2022: $4,816 · 2023: $2,702 · 2024: $2,324 · 2025: $3,135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,093 · Debt Forgiveness: $43.24 · Education: $25.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,092.62 |
| Debt Forgiveness | $43.24 |
| Education | $25.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,497.25 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $2,387.98 | 2019-2025 | Evenity, Prolia, Repatha |
| Biohaven Pharmaceutical Holding Company Ltd. | $2,195.09 | 2022 | |
| Gilead Sciences, INC. | $1,520.66 | 2019-2025 | Vemlidy, Epclusa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $957.95 | 2020-2025 | Jardiance, Synjardy |
| Amarin Pharma, INC. | $900.99 | 2019-2023 | |
| Novo Nordisk INC | $883.88 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $876.66 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $798.62 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $717.82 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $704.30 | 2019-2024 | Belsomra, Gardasil, Gardasil 9 |
| Pfizer INC. | $585.33 | 2019-2025 | |
| Abbvie INC. | $422.05 | 2021-2025 | |
| Echosens North America, INC. | $247.07 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $232.40 | 2021 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $217.75 | 2025 | Korlym |
| Genentech USA, INC. | $205.62 | 2019-2022 | |
| Optinose US, INC. | $151.86 | 2025 | |
| Janssen Pharmaceuticals, INC | $134.60 | 2021-2023 | Xarelto |
| Galderma Laboratories, L.P. | $125.48 | 2025 | |
| Esperion Therapeutics, INC. | $107.51 | 2020-2025 | Nexletol |
| Abbott Laboratories | $90.79 | 2021-2025 | Freestyle Libre 3 |
| Redhill Biopharma INC. | $89.22 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $86.52 | 2021 | |
| Exact Sciences Corporation | $68.42 | 2024-2025 | Cologuard Collection Kit |
| Eisai INC. | $68.00 | 2020-2022 | |
| Renalytix Ai, INC. | $64.42 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Dexcom, INC. | $63.27 | 2023-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.61 | 2019-2022 | |
| Mannkind Corporation | $48.62 | 2024 | |
| Shield Therapeutics INC | $46.66 | 2022 | |
| Optos, INC. | $43.24 | 2023 | Panoramic Ophthalmoscope |
| Boston Scientific Corporation | $37.95 | 2025 | Wavewriter Alpha Prime 16 |
| Horizon Therapeutics Plc | $37.07 | 2021-2022 | |
| Seqirus USA INC | $34.77 | 2020-2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Medtronic, INC. | $28.24 | 2022 | |
| Si-Bone, INC. | $27.86 | 2021 | |
| Inspire Medical Systems, INC. | $22.24 | 2024 | Inspire |
| Teva Pharmaceuticals USA, INC. | $20.70 | 2020 | |
| Merz North America, INC. | $20.55 | 2019 | |
| Astellas Pharma US INC | $19.86 | 2023 | Veozah |
| Nevro Corp. | $19.86 | 2023 | Senza |
| Takeda Pharmaceuticals U.S.A., INC. | $19.43 | 2022 | |
| Organon LLC | $19.06 | 2025 | |
| Novartis Pharmaceuticals Corporation | $18.83 | 2023 | |
| Eyevance Pharmaceuticals LLC | $17.97 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $17.87 | 2023 | Prehevbrio |
| Althera Pharmaceuticals LLC | $17.71 | 2021 | |
| Phadia US INC. | $17.53 | 2025 | Immunocap |
| Hologic Sales and Service, LLC | $17.17 | 2025 | Aptima, Thinprep 2000 Processor |
| Ars Pharmaceuticals Operations, INC. | $16.41 | 2025 | Neffy |
| Sanofi Pasteur INC. | $14.21 | 2019 | |
| Medicomp INC | $13.73 | 2024 | Telepatch Cardiac Monitor |
| Idorsia Pharmaceuticals US INC | $13.68 | 2023 | Quviviq |
| Napo Pharmaceuticals INC | $13.49 | 2025 | Mytesi |
| Scilex Pharmaceuticals INC. | $13.29 | 2019 | |
| Xeris Pharmaceuticals, INC. | $13.21 | 2024 | Gvoke Hypopen |
| Qiagen, LLC | $12.56 | 2022 | |
| Cequr Corporation | $10.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yan Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.